Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice

PLoS Pathogens

Volumn 7, Issue 12, 2011, Pages

  Ruckwardt, Tracy J ^a   Malloy, Allison M W ^a   Gostick, Emma ^b   Price, David A ^a,b   Dash, Pradyot ^c   McClaren, Jennifer L ^c   Thomas, Paul G ^c   Graham, Barney S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; M PROTEIN; PROTEIN M2; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; INTERFERON PRODUCTION; MALE; MOUSE; NEWBORN; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS LOAD; AGING; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY;

MUS; RESPIRATORY SYNCYTIAL VIRUS;

ADOPTIVE TRANSFER; AGING; ANIMALS; ANIMALS, NEWBORN; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; MALE; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRAL PROTEINS;

EID: 84855272559     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002377     Document Type: Article

References (50)

1. Paramore LC, Ciuryla V, Ciesla G, Liu L, (2004) Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 22: 275-284.
2. Hall CB, Long CE, Schnabel KC, (2001) Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis 33: 792-796.
3. Glezen WP, Taber LH, Frank AL, Kasel JA, (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140: 543-546.
4. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, et al. (1999) Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282: 1440-1446.
5. Marchant A, Newport M, (2000) Prevention of infectious diseases by neonatal and early infantile immunization: prospects for the new millennium. Curr Opin Infect Dis 13: 241-246.
6. Siegrist CA, (2001) Neonatal and early life vaccinology. Vaccine 19: 3331-3346.
7. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, et al. (2000) Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342: 232-239.
8. Barouch DH, Letvin NL, (2001) CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses. Curr Opin Immunol 13: 479-482.
9. Guidotti LG, Chisari FV, (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19: 65-91.
10. Mescher MF, Popescu FE, Gerner M, Hammerbeck CD, Curtsinger JM, (2007) Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors. Semin Cancer Biol 17: 299-308.
11. Yewdell JW, (2006) Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25: 533-543.
12. Zaghouani H, Hoeman CM, Adkins B, (2009) Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 30: 585-591.
13. McCarron MJ, Reen DJ, (2010) Neonatal CD8+ T-cell differentiation is dependent on interleukin-12. Hum Immunol 71: 1172-1179.
14. Garcia AM, Fadel SA, Cao S, Sarzotti M, (2000) T cell immunity in neonates. Immunol Res 22: 177-190.
15. Ridge JP, Fuchs EJ, Matzinger P, (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271: 1723-1726.
16. Rothenberg E, Triglia D, (1983) Clonal proliferation unlinked to terminal deoxynucleotidyl transferase synthesis in thymocytes of young mice. J Immunol 130: 1627-1633.
17. Bogue M, Candeias S, Benoist C, Mathis D, (1991) A special repertoire of alpha:beta T cells in neonatal mice. EMBO J 10: 3647-3654.
18. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, et al. (1993) The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 90: 4319-4323.
19. Martinez X, Regner M, Kovarik J, Zarei S, Hauser C, et al. (2003) CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles. Virology 305: 428-435.
20. Zhang J, Silvestri N, Whitton JL, Hassett DE, (2002) Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines. J Virol 76: 11911-11919.
21. Kovarik J, Bozzotti P, Love-Homan L, Pihlgren M, Davis HL, et al. (1999) CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J Immunol 162: 1611-1617.
22. Rutigliano JA, Ruckwardt TJ, Martin JE, Graham BS, (2007) Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. Virology 362: 314-319.
23. Dash P, McClaren JL, Oguin TH, 3rd, Rothwell W, Todd B, et al. (2011) Paired analysis of TCRalpha and TCRbeta chains at the single-cell level in mice. J Clin Invest 121: 288-295.
24. Billam P, Bonaparte KL, Liu J, Ruckwardt TJ, Chen M, et al. (2011) T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection. J Biol Chem 286: 4829-4841.
25. Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, et al. (2005) Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med 202: 1349-1361.
26. PrabhuDas M, Adkins B, Gans H, King C, Levy O, et al. (2011) Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 12: 189-194.
27. Graham BS, (2011) Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol Rev 239: 149-166.
28. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, et al. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89: 422-434.
29. Cormier SA, You D, Honnegowda S, (2010) The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert Rev Anti Infect Ther 8: 1371-1380.
30. Culley FJ, Pollott J, Openshaw PJ, (2002) Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 196: 1381-1386.
31. Dakhama A, Lee YM, Ohnishi H, Jing X, Balhorn A, et al. (2009) Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol 123: 138-145 e135.
32. Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, et al. (2005) The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol 175: 1876-1883.
33. Tasker L, Lindsay RW, Clarke BT, Cochrane DW, Hou S, (2008) Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge. Clin Exp Immunol 153: 277-288.
34. Tregoning JS, Yamaguchi Y, Harker J, Wang B, Openshaw PJ, (2008) The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J Virol 82: 4115-4124.
35. You D, Becnel D, Wang K, Ripple M, Daly M, et al. (2006) Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res 7: 107.
36. Graham BS, Perkins MD, Wright PF, Karzon DT, (1988) Primary respiratory syncytial virus infection in mice. J Med Virol 26: 153-162.
37. Harker JA, Lee DC, Yamaguchi Y, Wang B, Bukreyev A, et al. (2010) Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection. J Virol 84: 5294-5302.
38. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, et al. (1999) Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354: 541-545.
39. Rutigliano JA, Rock MT, Johnson AK, Crowe JE Jr, Graham BS, (2005) Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 337: 335-343.
40. Ruckwardt TJ, Luongo C, Malloy AM, Liu J, Chen M, et al. (2010) Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope. J Immunol 185: 4673-4680.
41. Feeney AJ, (1991) Junctional sequences of fetal T cell receptor beta chains have few N regions. J Exp Med 174: 115-124.
42. Feeney AJ, (1993) Junctional diversity in the absence of N regions. Neonatal T cell receptor beta chain junctional sequences are more heterogeneous than neonatal T cell receptor gamma delta or IgH junctions. J Immunol 151: 3094-3099.
43. Rudd BD, Venturi V, Davenport MP, Nikolich-Zugich J, (2011) Evolution of the antigen-specific CD8+ TCR repertoire across the life span: evidence for clonal homogenization of the old TCR repertoire. J Immunol 186: 2056-2064.
44. Kotturi MF, Scott I, Wolfe T, Peters B, Sidney J, et al. (2008) Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol 181: 2124-2133.
45. Obar JJ, Khanna KM, Lefrancois L, (2008) Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 28: 859-869.
46. Schmidt J, Neumann-Haefelin C, Altay T, Gostick E, Price DA, et al. (2011) Immunodominance of HLA-A2-Restricted Hepatitis C Virus-Specific CD8+ T Cell Responses Is Linked to Naive-Precursor Frequency. J Virol 85: 5232-5236.
47. La Gruta NL, Rothwell WT, Cukalac T, Swan NG, Valkenburg SA, et al. (2010) Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J Clin Invest 120: 1885-1894.
48. Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, et al. (2006) Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J Infect Dis 194: 1638-1649.
49. Moon JJ, Chu HH, Hataye J, Pagan AJ, Pepper M, et al. (2009) Tracking epitope-specific T cells. Nat Protoc 4: 565-581.
50. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, et al. (2007) Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.